Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07434011

Efficacy of Artificial Intelligence-Assisted Therapeutic Exercise in Patients With Knee Osteoarthritis

Knee osteoarthritis is a common, chronic degenerative condition that causes pain, functional limitations, and reduced quality of life, especially in adults older than 50 years. Although clinical practice guidelines recommend therapeutic exercise and physical therapy as the first-line treatment, many patients do not receive or adhere to the recommended programs. Digital health tools may help expand access and improve adherence by supporting home-based exercise.

This study is a parallel-group, randomized controlled clinical trial designed to evaluate the effectiveness of an artificial intelligence (AI)-assisted therapeutic exercise program delivered through a web-based app compared with a conventional home exercise program provided on paper in adults with knee osteoarthritis. The primary goal is to determine whether the AI-assisted program produces greater improvements in pain and knee-related function. Secondary goals include assessing changes in health-related quality of life and patient-perceived overall improvement, and comparing implementation outcomes like adherence, usability, satisfaction, self-efficacy for exercise, and use of the prescribed exercise resource (paper vs web platform). Participants will be recruited from the Department of Physical Medicine and Rehabilitation at Hospital Universitario 12 de Octubre and randomly assigned to either the AI-assisted exercise group or the conventional exercise group. The AI-assisted web app will adjust exercise dose and progression based on participant-reported pain and perceived exertion, using decision rules informed by clinical practice guidelines and high-quality research evidence. Both groups will complete a 6-week home-based exercise program and will also attend weekly in-person group sessions that will be held separately by study arm (experimental and control groups will not mix) to reduce cross-contamination and support masking procedures. These sessions will be used to address questions, reinforce the protocol, and monitor for adverse events. Clinical outcomes will include pain intensity (visual analog scale), knee-related disability and function (WOMAC), health-related quality of life (EQ-5D), and patient global rating of change (GROC). Physical performance outcomes (30-second Chair Stand Test and Stair Climb Test) will be assessed at baseline and 1 week after completion of the 6-week intervention. Assessments will be conducted at baseline, one week after the 6-week intervention, and at 3 and 6 months after the intervention, with the exception of physical performance outcomes, which will be assessed at baseline and 1 week post-intervention.

Recruiting

Interested in participating?

Request Info

Key information

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Universitario 12 de Octubre

Madrid, 28041, Spain

Location status: Recruiting

Location contact

Marcos José N Marcos José Navarro-Santana

CONTACT

[email protected]

0034 91 394 15 24

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(based on National Institute for Health and Care Excellence (NICE) guidance):

  • Clinical criteria for KOA: age ≥45 years, activity-related knee pain, and morning knee stiffness lasting ≤30 minutes.
  • Knee pain for 3 months or longer.
  • Knee pain on most days during the previous month.
  • Overall knee pain intensity ≥4 on an 11-point Numerical Rating Scale (NRS; 0-10) during the previous week.
  • Ownership of a smartphone and ability to use a mobile application.
  • Internet access at home and/or via the mobile phone.
  • Ability to provide informed consent, participate, and complete study assessments.

Exclusion criteria

  • Having a planned knee arthroplasty (knee replacement) surgery.
  • Knee prosthesis/arthroplasty in the most painful knee.
  • Participation in a therapeutic exercise program for knee osteoarthritis within the past 6 weeks.
  • Infiltration for knee osteoarthritis within the past 12 weeks.
  • Inflammatory arthritic conditions.
  • A fall in the past 12 months without medical clearance to perform unsupervised home exercise.
  • Being homebound during the past month without medical clearance to perform unsupervised home exercise.
  • Failing the pre-exercise screening and not having medical clearance to perform unsupervised home exercise.
  • Inability to communicate in Spanish.
  • Any neurological or systemic disease that may limit participation in the study.

Treatment and study plan

AI-Assisted Exercise Program

Other

Participants will complete a 6-week home-based therapeutic exercise program delivered through an AI-assisted web application. The program will be individualized and updated based on participant-reported pain and perceived exertion, which will be used to guide exercise dose and progression (e.g., progression/regression, load adjustments, and exercise variants) according to guideline-informed decision rules embedded in the platform. Participants will also attend weekly in-person, arm-specific group sessions (experimental-only) for protocol reinforcement, questions, and adverse event monitoring.

Paper-Based Home Exercise Program

Other

Participants will complete a 6-week home-based therapeutic exercise program provided in paper format (printed exercise materials). The program will follow a conventional, predefined progression consistent with usual care and will not incorporate real-time, individualized adjustments based on symptom/effort inputs. Participants will also attend weekly in-person, arm-specific group sessions (control-only) for protocol reinforcement, questions, and adverse event monitoring.

Primary outcomes

  1. Pain Intensity

    Time frame: Baseline, 1 week post-intervention, 3 months post-intervention and 6 months post-intervention

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), a single 11-point numerical rating scale widely validated across different patient populations, where 0 represents no pain and 10 represents the worst possible pain. Data obtained through the NPRS are easy to document, intuitively interpretable and meet regulatory requirements for pain assessment and documentation.

Secondary outcomes

  1. Disability

    Time frame: Baseline, 1 week post-intervention, 3 months post-intervention and 6 months post-intervention

    Pain, stiffness and self-reported physical function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index short form (WOMAC-SF), a patient-reported outcome measure designed to quantify symptom severity and functional limitations typically associated with hip and knee osteoarthritis. Items will be summed to obtain a total score ranging from 0 to 44 points, where higher results indicate worse symptoms and greater functional limitation.

  2. Health-related quality of life

    Time frame: Baseline, 1 week post-intervention, 3 months post-intervention and 6 months post-intervention

    Health-related quality of life will be assessed using the EuroQol EQ-5D-5L, a standardized, generic measure of self-reported health status widely used in clinical and health-economic research. The EQ-5D-5L comprises two components: (1) a descriptive system and (2) a visual analogue scale (EQ VAS). The descriptive system covers five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated across five severity levels (from no problems to extreme problems). Responses are combined into a 5-digit health state (e.g., 11,121), which is then converted into a single utility index using a country-specific value set; in this study, the Spanish value set will be applied for index derivation. The EQ VAS records the participant's overall health "today" on a 0-100 scale, where 0 represents the worst imaginable health and 100 the best imaginable health. The EQ-5D-5L has demonstrated validity and provides reference norms for the Spanish population.

  3. Lower-limb functional performance

    Time frame: Baseline and 1 week post-intervention

    Lower-limb functional performance will be assessed using the 30-Second Chair Stand Test (30CST), a pragmatic, clinic-friendly measure of functional strength and endurance of the lower extremities. In this test, participants will be instructed to rise to a full stand and sit down as many times as possible within 30 seconds, starting from a standard chair (without armrests), with arms crossed over the chest (or following a standardized alternative if needed for safety). The primary outcome is the number of fully completed sit-to-stand repetitions in 30 seconds, where higher values indicate better functional performance.

  4. Lower-limb stair-climbing function

    Time frame: Baseline and 1 week post-intervention

    Lower-limb stair-climbing function will be assessed using a Timed Stair Test consisting of 11 steps, a pragmatic measure of lower-extremity functional capacity during stair ascent and descent. Participants will be instructed to ascend and then descend a flight of 11 stairs as quickly and safely as possible, starting from a standardized position. The primary outcome will be time to completion (seconds), recorded from the initiation of movement to the moment the participant returns to the starting level after completing both ascent and descent; shorter times indicate better lower-limb function.

  5. Perceived overall change (Patient Global Rating of Change, GROC)

    Time frame: 1 week post-intervention, 3 months post-intervention and 6 months post-intervention

    Participants' perceived overall change will be assessed using the Patient Global Rating of Change (GROC), a single-item anchor measure designed to capture the participant's global perception of improvement or deterioration since baseline. Participants will be asked to rate how their condition has changed compared with the start of the study on a 15-point scale ranging from -7 to +7, where -7 indicates "a very great deal worse," 0 indicates "no change," and +7 indicates "a very great deal better." The primary outcome will be the GROC score at each follow-up, with positive values reflecting improvement and negative values reflecting worsening.

Sponsors and collaborators

Lead sponsor

Universidad Complutense de Madrid

Other

Collaborators

  • Hospital Universitario 12 de Octubre

Registry information

Official study title

Efficacy of Artificial Intelligence-Assisted Therapeutic Exercise in Patients With Knee Osteoarthritis: A Randomized Controlled Clinical Trial

Acronym: ET-AIAR

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 25, 2026
Registry last updated
May 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.